News & Alerts

Advocate Leadership Summit: April 25-28, 2026

Registration for NBCC’s 2026 Advocate Leadership Summit is now open! Join us at our new location– the Washington Marriott at Metro Center–  from April 25-27 for a weekend of exciting programming, followed by Lobby Day on Capitol Hill on April 28. 

The Summit prepares advocates to take a meaningful seat at the table wherever breast cancer decisions are made. Advocates will come away invigorated and inspired to fight to end the disease.

Learn More and Register

At the 2026 Summit, you will:

• Network with some of the most highly committed and motivated advocate leaders in the world of breast cancer.
• Interact with scientists, thought leaders, innovators, and visionaries in small, intimate groups.
• Receive dynamic, world-class leadership training.
• Hear about cutting-edge breast cancer research.
• Examine important issues that stifle progress toward ending breast cancer.
• Prepare to advocate on Capitol Hill for NBCC’s public policy and legislative priorities.
• Learn best practices from successful advocate leaders.

Project LEAD: July 26–31, 2026

Apply to attend Project LEAD, NBCC’s premier science training program for breast cancer advocates. During the six-day course, renowned research faculty teach advocates the basics of cancer biology, genetics, epidemiology, research design, and advocacy, providing them with a foundation of scientific knowledge upon which they can strengthen and empower themselves as activists.

Learn more about Project LEAD and whether it could be the right next step in your breast cancer advocacy journey.

Apply Now

Project LEAD attendees are: 

• Interested in learning the scientific language and concepts of breast cancer to share with their community.
• Motivated to take a seat at the tables where important breast cancer decisions are made.
• Dedicated to supporting NBCC’s mission to end breast cancer for everyone.
• Actively involved with a breast cancer organization.
• Individuals with a personal connection to breast cancer.